Ocular complications in the Department of Defense Smallpox Vaccination Program

Ophthalmology

Volumn 111, Issue 11, 2004, Pages 2086-2093

  Fillmore, Gary L ^a   Ward, Thomas P ^a   Bower, Kraig S ^a   Dudenhoefer, Eric J ^b   Grabenstein, John D ^c   Berry, G Keith ^b   Madigan Jr , William P ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

^c Office of the Surgeon General   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE; TRIFLURIDINE;

ADULT; BLEPHARITIS; CASE REPORT; CELLULITIS; CLINICAL FEATURE; CONJUNCTIVA DISEASE; CONJUNCTIVITIS; CORNEA ULCER; DATA ANALYSIS; EYE DISEASE; EYELID; GOVERNMENT; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; INOCULATION; IRITIS; MALE; OCULAR VACCINIA; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUSTULE; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SMALLPOX; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

EID: 7444250653     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.04.027     Document Type: Article

References (32)

1. Barquet N., Domingo P. Smallpox the triumph over the most terrible of the ministers of death. Ann Intern Med. 127:1997;635-642
2. World Health Organization. Declaration of the global eradication of smallpox. Wkly Epidemiol Rec. 55:1980;148
3. Centers for Disease Control and Prevention. Smallpox fact sheet: smallpox disease overview Available at: http://www.bt.cdc.gov/agent/smallpox/overview/ disease-facts.asp. Accessed November 1, 2003
4. Advisory Committee on Immunization Practices. Vaccinia (smallpox) vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001;50(RR-10):1-25 Available at: http://www.cdc.govmmwr/preview/mmwrhtml/rr5010a1.htm. Accessed October 15, 2003
5. Bozzette S.A., Boer R., Bhatnagar V., et al. A model for a smallpox-vaccination policy. N Engl J Med. 348:2003;416-425
6. Blendon R.J., DesRoches C.M., Benson J.M., et al. The public and the smallpox threat. N Engl J Med. 348:2003;426-432
7. Working Group on Civilian Biodefense, Henderson D.A., Inglesby T.V., Bartlett J.G., et al. Smallpox as a biological weapon medical and public health management. JAMA. 281:1999;2127-2137
8. Lane J.M., Goldstein J. Evaluation of 21st-century risks of smallpox vaccination and policy options. Ann Intern Med. 138:2003;488-493
9. Advisory Committee on Immunization Practices Centers for Disease Control and Prevention, Wharton M.D., Strikas R.A., Harpaz R., et al. Recommendations for using smallpox vaccine in a pre-event vaccination program supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 52:(RR-7):2003;1-16
10. Grabenstein J.D., Winkenwerder W. Jr. US military smallpox vaccination program experience. JAMA. 289:2003;3278-3282
11. The White House. Protecting Americans: Smallpox Vaccination Program. Available at: http://www.whitehouse.gov/news/releases/2002/12/20021213-1.html. Accessed October 15, 2003
12. Lane J.M., Ruben F.L., Neff J.M., Millar J.D. Complications of smallpox vaccination, 1968. N Engl J Med. 281:1969;1201-1208
13. Lane J.M., Ruben F.L., Neff J.M., Millar J.D. Complications of smallpox vaccination, 1968 results of ten statewide surveys. J Infect Dis. 122:1970;303-309
14. Neff J.M., Lane J.M., Pert J.H., et al. Complications of smallpox vaccination I. National survey in the United States, 1963. N Engl J Med. 276:1967;125-132
15. Ruben F.L., Lane J.M. Ocular vaccinia an epidemiologic analysis of 348 cases. Arch Ophthalmol. 84:1970;45-48
16. Jelinek J.E. Localized accidental vaccination of the eye. Arch Derm. 99:1969;504
17. Rennie A.G., Cant J.S., Foulds W.S., et al. Ocular vaccinia. Lancet. 2:1974;273-275
18. Lee S.F., Buller R., Chansue E., et al. Vaccinia keratouveitis manifesting as a masquerade syndrome. Am J Ophthalmol. 117:1994;480-487
19. Goldstein J.A., Neff J.M., Lane J.M., Koplan J.P. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics. 55:1975;342-347
20. Pepose J.S., Margolis T.P., LaRussa P., Pavan-Langston D. Ocular complications of smallpox vaccination. Am J Ophthalmol. 136:2003;343-352
21. Zhou W., Pool V., Iskander J., et al. Surveillance for safety after immunization Vaccine Adverse Events Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Summ. 52:2003;1-24
22. Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program. MMWR Morb Mortal Wkly Rep 2003;52:88-9, 99
23. Centers for Disease Control and Prevention. Smallpox vaccination and adverse events training module. Available at: http://www.bt.cdc.gov/training/ smallpoxvaccine/reactions/laboratory_testing.html. Accessed October 15, 2003
24. Sepkowitz K.A. How contagious is vaccinia? N Engl J Med. 348:2003;439-446
25. Smith P.F., Chang H., Sepkowitz K.A. Inpatients at risk of contact vaccinia from immunized health care workers [letter]. JAMA. 289:2003;1512-1513
26. Cono J., Casey C.G., Bell D.M. Smallpox vaccination and adverse reactions guidance for clinicians. MMWR Recomm Rep. 52:(RR-4):2003;1-28
27. Jack M.K., Sorenson R.W. Vaccinial keratitis treated with IDU. Arch Ophthalmol. 69:1963;730-732
28. Pavan-Langston D., Dohlman C.H. A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. Am J Ophthalmol. 74:1972;81-88
29. Hyndiuk R.A., Seideman S., Leibsohn J.M. Treatment of vaccinial keratitis with trifluorothymidine. Arch Ophthalmol. 94:1976;1785-1786
30. Hyndiuk R.A., Okumoto M., Damiano R.A., et al. Treatment of vaccinial keratitis with vidarabine. Arch Ophthalmol. 94:1976;1363-1364
31. Elion G.B., Rideout J.L., de Miranda P., et al. Biological activities of some purine arabinosides. Ann N Y Acad Sci. 255:1975;468-480
32. Fulginiti V.A., Winograd L.A., Jackson M., Ellis P. Therapy of experimental vaccinal keratitis effect of idoxuridine and VIG. Arch Ophthalmol. 74:1965;539-544